Orthofix Medical Inc.
OFIX
$12.03
$0.161.35%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 26.83% | -0.08% | -2.67% | -13.12% | 16.78% |
| Total Depreciation and Amortization | -17.95% | 13.62% | 54.87% | 52.40% | 25.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -10.90% | 1.82% | -10.91% | 5.17% | -4.01% |
| Change in Net Operating Assets | -11.67% | 57.41% | 47.24% | 63.70% | 64.33% |
| Cash from Operations | 29.30% | 734.01% | 281.00% | 185.71% | 156.37% |
| Capital Expenditure | 0.72% | 24.40% | 52.03% | 49.84% | 43.79% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -99.62% | 517.14% | 842.13% | 2,246.96% | 1,559.20% |
| Cash from Investing | -25.45% | 40.09% | 64.07% | 61.61% | 16.75% |
| Total Debt Issued | -- | 9.07% | -3.61% | -7.02% | 13.24% |
| Total Debt Repaid | 99.47% | -35.43% | -35.44% | -35.45% | -34.40% |
| Issuance of Common Stock | -5.24% | -0.41% | 3.01% | 23.00% | 22.04% |
| Repurchase of Common Stock | 91.87% | 91.13% | 66.11% | 18.35% | -20.81% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -19.24% | -22.02% | 39.13% | 26.69% | -37.92% |
| Cash from Financing | -101.55% | -36.35% | -52.43% | -59.59% | -22.37% |
| Foreign Exchange rate Adjustments | 250.75% | 5.57% | 788.11% | -241.23% | -251.53% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -101.30% | 3,111.00% | 555.59% | 251.14% | 470.71% |